These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt, with results 2007-004819-54 A phase I/II, open label, escalating dose, pilot study to assess the effect, safety, tolerability and pharmacokinetics of multiple subcutaneous doses of drisapersen in patients with Duchenne muscular ... 2016-09-09 not-yet-due
Exempt, with results 2009-013762-63 A phase I/IIa, open label, escalating dose, pilot study to assess the effect, safety, tolerability and pharmacokinetics of multiple subcutaneous and intravenous doses of PRO044 in patients with Duchen... 2013-07-30 not-yet-due
Exempt, with results 2011-005040-10 A phase IIb, open-label study to assess the efficacy, safety, pharmacodynamics and pharmacokinetics of multiple doses of BMN 045 (previously known as PRO045) in subjects with Duchenne muscular dystrop... 2016-09-09 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-005042-35 A Phase I/II, open-label, dose escalating with 48 week treatment study to assess the safety and tolerability, pharmacokinetics, pharmacodynamics and efficacy of BMN 053 (previously known as PRO053) in... 2016-09-09 bad-data
Reported results 2013-003605-26 A phase II, open label, extension study to assess the effect of PRO044 in patients with Duchenne muscular dystrophy 2016-08-05 due-trials